Clinical trials
Infections clinical trials
Below are recruiting infections clinical trials, each written for real people, not researchers. We’re tracking 1,755 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07555431RecruitingPhase 2
Dolutegravir alone versus with tenofovir for HTLV-1
This study tests whether adding tenofovir (an antiviral medication) to dolutegravir helps treat HTLV-1 infection better than dolutegravir alone. HTLV-1 is a virus that can cause serious health problems, and researchers want to find the most effective treatment combination.
Salvador, Estado de BahiaAges 18 years+ - NCT07559318Recruiting
Optimizing Antibiotic Choice for Urinary Tract Infections
This study helps doctors choose the best antibiotic for urinary tract infections (UTIs) by looking at urine culture results. You'll be treated as an outpatient (at home) and monitored to see if your antibiotic is working well.
MelunAges 18 years+ - NCT07593547Recruiting
Combination vs. single drug for Stenotrophomonas infection
This study compares treating Stenotrophomonas maltophilia (a hospital-acquired bacterial infection) with two drugs together versus one drug alone. The goal is to see which approach works better and is safer for adult hospital patients.
Madrid, MadridAges 18 years+ - NCT07601711Recruiting
Sulbactam-Durlobactam for Drug-Resistant Bacterial Infections
This study tracks hospitalized patients receiving a specific antibiotic combination (sulbactam-durlobactam) to treat a serious, hard-to-treat bacterial infection called CRAB. Researchers want to understand how well this treatment works in real-world hospital settings.
Chengdu, SichuanAges 18 years+ - NCT07651865Recruiting
Testing New Ways to Diagnose Respiratory Infections
This study tests new diagnostic tools to help quickly identify what's causing your respiratory infection. You'll provide samples (like nasal swabs) to help researchers understand how these new tests work in real patients.
Addis AbabaAges 6 months+ - NCT07615309Enrolling by invitation
Omadacycline for Mycobacterium abscessus lung infection
This trial tests whether omadacycline (an antibiotic) can safely and effectively treat a rare lung infection caused by Mycobacterium abscessus bacteria. If you have this infection, this study may help doctors understand if this antibiotic works better than current treatments.
BeijingAges 18 years+ - NCT07264296Enrolling by invitation
Infection after bone cancer surgery with a big joint implant
This trial studies infections that happen after surgery for bone cancer where a large artificial joint is placed. It aims to understand why some patients get infections, which may lead to better prevention or treatment.
GothenburgAges Any age - NCT07176247Enrolling by invitation
Study of aztreonam-avibactam for drug-resistant infections
This trial studies a combination antibiotic called aztreonam-avibactam for treating infections caused by hard-to-treat bacteria, especially those that produce certain enzymes (MBLs). It aims to see how well this medicine works in hospital patients.
ParisAges Any age - NCT07164781Enrolling by invitation
Probiotics for preventing infections in ICU patients
This trial tests whether probiotics (good bacteria) can help prevent serious infections in critically ill patients in the ICU. If you are very sick and in the ICU, you may be able to join — as long as you don't have certain conditions like cancer or a weakened immune system.
Banhā, Qalyubia GovernorateAges 18 years+ - NCT07008040Enrolling by invitation
Silver dressing to prevent infection after heart surgery
This trial tests whether a special silver dressing placed on the surgical wound after heart surgery can prevent infections. If you are scheduled for heart surgery through a breastbone cut, you may be eligible to join.
JeddahAges 18 years+ - NCT06957236Enrolling by invitation
NICE Procedure for Benign Colon Disease
This trial tests a new minimally invasive surgery called the NICE procedure for treating benign left-sided colon diseases like diverticulitis or benign polyps. It aims to see if this approach leads to fewer infections and better recovery compared to standard surgery.
Houston, TexasAges 18 years+ - NCT06728930Enrolling by invitation
New test for diagnosing latent and active TB
This study tests a new type of lab test to find TB bacteria more accurately. It is for people who are being checked for latent (hidden) TB infection, or who have just been diagnosed with active TB. The goal is to see if the new test can help doctors diagnose TB better and faster.
LondonAges 18 years+ - NCT05492565Enrolling by invitation
Follow-up study for people on HIV prevention pills
This study follows adults who are at high risk of getting HIV while they take HIV prevention pills (PrEP). It aims to learn how well PrEP fits real-life use in people at risk and who may need extra care.
Seville, AndalusiaAges 18 years+ - NCT05224583Enrolling by invitation
Study BK virus after combined liver and kidney transplant
This study looks at how often BK virus shows up in people after a combined liver-kidney transplant. It may help the transplant team better predict and manage this virus after surgery.
Dallas, TexasAges 18–100 - NCT07395518Enrolling by invitation
Drain placement in c-section for women with thick belly fat
This trial tests if placing a small drain under the skin during a cesarean section reduces surgical site infections in women with a belly fat thickness of 4 cm or more. It may help prevent infections and improve recovery.
Chon Buri, Changwat Chon BuriAges 18 years+ - NCT06925321RecruitingPhase 3
Testing Fosmanogepix for Serious Mold Infections
This trial tests a new drug, Fosmanogepix, for treating serious mold infections that are hard to treat with current medicines. It may be an option for people with limited treatment choices.
Birmingham, AlabamaAges 18 years+ - NCT06439953Recruiting
Irrigation solution for spinal surgery instrumentation
This trial tests a solution used to clean the surgical site during spine surgeries to see if it helps prevent infections. It is for patients having certain types of spine surgery for conditions like deformity, cancer, or trauma.
Providence, Rhode IslandAges 18 years+ - NCT04665037RecruitingPhase 2
Posaconazole study for infants under 2 with serious fungal infection
This trial tests whether posaconazole, given through a vein or by mouth, can treat invasive fungal infections in children under 2 years old. It may help improve outcomes for infants with hard-to-treat fungal disease.
San Diego, CaliforniaAges 1 day–2 years - NCT07513285RecruitingPhase 2
Ibezapolstat pill for recurrent C. difficile infection
This trial tests a new oral antibiotic called ibezapolstat to treat recurrent C. difficile infection (CDI)—a serious diarrheal illness caused by bacteria in your gut. The study focuses on patients who have had multiple CDI episodes and may benefit from a different treatment approach.
Sacramento, CaliforniaAges 18–90 - NCT07220915RecruitingPhase 3
Study of Panzyga to prevent infections in people with weak immune systems
This trial tests if a medication called Panzyga can help prevent infections in people with autoimmune conditions who have low antibody levels after B-cell therapy. It may be an option if you have a condition like multiple sclerosis, rheumatoid arthritis, or lupus.
Scottsdale, ArizonaAges 18 years+ - NCT07387367RecruitingPhase 3
Comparing two drugs for adenovirus after stem cell transplant
This trial tests a new drug, brincidofovir (BCV), against an existing drug, cidofovir (CDV), for treating adenovirus infection in people who recently had a stem cell transplant. The goal is to see which works better with fewer side effects.
Phoenix, ArizonaAges 2 months+ - NCT05592626RecruitingPhase 1/Phase 2
T cell activator STAR0602 for advanced solid tumors
This study tests an experimental drug called STAR0602 that aims to boost your immune system's T cells to fight advanced solid tumors. It's for patients whose cancer has not responded to standard treatments or for whom such treatments are not suitable.
Sacramento, CaliforniaAges 18 years+ - NCT07508124RecruitingPhase 4
Steroid cream to prevent repeat UTIs in uncircumcised baby boys
This study tests if a steroid cream applied to the foreskin can help prevent another urinary tract infection (UTI) in uncircumcised baby boys under 6 months old who have already had one confirmed UTI.
Houston, TexasAges birth–5 months - NCT06775496Recruiting
Study of life-threatening infections to find genetic causes
This trial studies people who have had a life-threatening infection to look for genetic reasons why some infections are so severe. If you or a child had a serious infection—like severe flu, meningitis, or a deep abscess—that could not be explained by a weak immune system from other causes, this study may help find answers.
Bologna, BolognaAges Any age
Hear when a new Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for infections?
- Yes. Clin2 currently lists 1,755 recruiting infections studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a infections trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a infections trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.